Iluria is redefining how mental health treatment is monitored by harnessing data-driven insights from commercial-grade wearables. Our platform enables continuous, evidence-based tracking of medication response, accelerating time to effective treatment and improving patient adherence.
Our first solution focuses on monitoring treatment for ADHD, providing clinicians and patients with actionable insights to optimize care.
We are looking to raise $500K for initial commercialization with private mental health clinics.
Current traction includes:
• Fully functional first version operating on commercial-grade smartwatches
• validated through four successful clinical trials
• vPiloting processes with 3 institutional HCPs
• Validated both Class1 reimbursement pathway (RTM/RPM codes) and regulatory pathway (510K class 2 – predicate device allocated)
• Secured intellectual property:
 – Granted US patent for ADHD treatment monitoring
 – Pending national phase patent for anxiety and depression monitoring